entertainment -WSS

entertainment

author：comprehensive 2025-09-29 09:55:09 - browse：945

A sign of pharmaceutical company Bayer in front of a blossomed tree — coverage from STAT — INA FASSBENDER/AFP via Getty Images

More hopeful news on the menopause front: Bayer announced on Monday encouraging results in two Phase 3 trials for its non-hormonal drug candidate, elinzanetant, meant to treat hot flashes. The results follow the recent market launch of Veozah, Astellas Pharma’s groundbreaking non-hormonal treatment for hot flashes, which was approved by the U.S. Food and Drug Administration last spring and received approval in the U.K., under the name Veozah, in December.

Elinzanetant is a neurokinin-1 and 3 receptor antagonist, and works by calming down the estrogen receptors in the brain that become hyperactive around menopause, causing hot flashes. The drug, a pill administered once a day, was shown to reduce both the frequency and intensity of hot flashes, and also met the secondary endpoints for improving sleep and quality of life, according to JoAnn Pinkerton, professor of obstetrics and gynecology and director of the Midlife Health at UVA Health, who is a clinical investigator for Bayer’s drug candidate.

Pinkerton said she was excited to see the broader quality of life improvements through elinzanetant: “Women have more than just hot flashes — it’s actually more about hot flushes, sweats, fatigue, lack of sleep and some of the mood changes that go on during [menopause].”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Swim instructor mom warns parents not to buy blue swimsuits for kids

explore

hotspot

WSS

Biotech stock slump in 2023: awaiting the turnaround

Second xenotransplant done with gene

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

Recent heat wave in the Mediterranean caused by climate change: Study

Biden’s NIH nominee is languishing in Congress

leisure time

entertainment

Wikipedia

Medical records are filled with copy

CommonSpirit Health keeps growing, even as it loses money

Supreme Court strikes down use of affirmative action

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Supreme Court strikes down use of affirmative action

Lasker Awards 2023: Winners in biomedical research

Wildfire smoke exposes gaps in outdoor worker protections

Biden targets hefty hospital 'facility fees' that often surprise patients

Affirmative action in medical school literally saved lives

Biden declares emergency in flood

knowledge

Swim instructor mom warns parents not to buy blue swimsuits for kids

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

Eisai exec who led development of Alzheimer’s drug to retire

Ukraine and a new approach to mental health in war

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

Hearing on Medicare drug price negotiation gets unusually heated

explore

focus

hotspot

hotspot